Global ADHD Medications Market Growth (Status and Outlook) 2025-2031

December 2025 | 95 pages | ID: G6CA7C0597B6EN
LP Information

Abstracts

According to this study, the global ADHD Medications market size will reach US$ 1483 million by 2031.

ADHD Medications are pharmaceutical drugs prescribed to individuals with Attention-Deficit/Hyperactivity Disorder (ADHD). These medications aim to improve attention, focus, and impulse control.

The market for ADHD Medications is driven by the diagnosis and treatment of ADHD. Ongoing research and developments focus on improving the effectiveness and minimizing side effects of these medications.

LPI (LP Information)' newest research report, the “ADHD Medications Industry Forecast” looks at past sales and reviews total world ADHD Medications sales in 2024, providing a comprehensive analysis by region and market sector of projected ADHD Medications sales for 2025 through 2031. With ADHD Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ADHD Medications industry.

This Insight Report provides a comprehensive analysis of the global ADHD Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ADHD Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ADHD Medications market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ADHD Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ADHD Medications.

This report presents a comprehensive overview, market shares, and growth opportunities of ADHD Medications market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Stimulant
• Non-stimulant

Segmentation by Application:

• Adult
• Children

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Amneal Pharmaceuticals
• Eli Lilly and Co.
• Johnson and Johnson Services
• NEOS Therapeutic
• Takeda Pharmaceutical
• Pfizer
• Lupin
• Shire
• Mallinckrodt

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global ADHD Medications Market Size (2020-2031)
  2.1.2 ADHD Medications Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for ADHD Medications by Country/Region (2020, 2024 & 2031)
2.2 ADHD Medications Segment by Type
  2.2.1 Stimulant
  2.2.2 Non-stimulant
2.3 ADHD Medications Market Size by Type
  2.3.1 ADHD Medications Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global ADHD Medications Market Size Market Share by Type (2020-2025)
2.4 ADHD Medications Segment by Application
  2.4.1 Adult
  2.4.2 Children
2.5 ADHD Medications Market Size by Application
  2.5.1 ADHD Medications Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global ADHD Medications Market Size Market Share by Application (2020-2025)

3 ADHD MEDICATIONS MARKET SIZE BY PLAYER

3.1 ADHD Medications Market Size Market Share by Player
  3.1.1 Global ADHD Medications Revenue by Player (2020-2025)
  3.1.2 Global ADHD Medications Revenue Market Share by Player (2020-2025)
3.2 Global ADHD Medications Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ADHD MEDICATIONS BY REGION

4.1 ADHD Medications Market Size by Region (2020-2025)
4.2 Global ADHD Medications Annual Revenue by Country/Region (2020-2025)
4.3 Americas ADHD Medications Market Size Growth (2020-2025)
4.4 APAC ADHD Medications Market Size Growth (2020-2025)
4.5 Europe ADHD Medications Market Size Growth (2020-2025)
4.6 Middle East & Africa ADHD Medications Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas ADHD Medications Market Size by Country (2020-2025)
5.2 Americas ADHD Medications Market Size by Type (2020-2025)
5.3 Americas ADHD Medications Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC ADHD Medications Market Size by Region (2020-2025)
6.2 APAC ADHD Medications Market Size by Type (2020-2025)
6.3 APAC ADHD Medications Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe ADHD Medications Market Size by Country (2020-2025)
7.2 Europe ADHD Medications Market Size by Type (2020-2025)
7.3 Europe ADHD Medications Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa ADHD Medications by Region (2020-2025)
8.2 Middle East & Africa ADHD Medications Market Size by Type (2020-2025)
8.3 Middle East & Africa ADHD Medications Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ADHD MEDICATIONS MARKET FORECAST

10.1 Global ADHD Medications Forecast by Region (2026-2031)
  10.1.1 Global ADHD Medications Forecast by Region (2026-2031)
  10.1.2 Americas ADHD Medications Forecast
  10.1.3 APAC ADHD Medications Forecast
  10.1.4 Europe ADHD Medications Forecast
  10.1.5 Middle East & Africa ADHD Medications Forecast
10.2 Americas ADHD Medications Forecast by Country (2026-2031)
  10.2.1 United States Market ADHD Medications Forecast
  10.2.2 Canada Market ADHD Medications Forecast
  10.2.3 Mexico Market ADHD Medications Forecast
  10.2.4 Brazil Market ADHD Medications Forecast
10.3 APAC ADHD Medications Forecast by Region (2026-2031)
  10.3.1 China ADHD Medications Market Forecast
  10.3.2 Japan Market ADHD Medications Forecast
  10.3.3 Korea Market ADHD Medications Forecast
  10.3.4 Southeast Asia Market ADHD Medications Forecast
  10.3.5 India Market ADHD Medications Forecast
  10.3.6 Australia Market ADHD Medications Forecast
10.4 Europe ADHD Medications Forecast by Country (2026-2031)
  10.4.1 Germany Market ADHD Medications Forecast
  10.4.2 France Market ADHD Medications Forecast
  10.4.3 UK Market ADHD Medications Forecast
  10.4.4 Italy Market ADHD Medications Forecast
  10.4.5 Russia Market ADHD Medications Forecast
10.5 Middle East & Africa ADHD Medications Forecast by Region (2026-2031)
  10.5.1 Egypt Market ADHD Medications Forecast
  10.5.2 South Africa Market ADHD Medications Forecast
  10.5.3 Israel Market ADHD Medications Forecast
  10.5.4 Turkey Market ADHD Medications Forecast
10.6 Global ADHD Medications Forecast by Type (2026-2031)
10.7 Global ADHD Medications Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market ADHD Medications Forecast

11 KEY PLAYERS ANALYSIS

11.1 Amneal Pharmaceuticals
  11.1.1 Amneal Pharmaceuticals Company Information
  11.1.2 Amneal Pharmaceuticals ADHD Medications Product Offered
  11.1.3 Amneal Pharmaceuticals ADHD Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Amneal Pharmaceuticals Main Business Overview
  11.1.5 Amneal Pharmaceuticals Latest Developments
11.2 Eli Lilly and Co.
  11.2.1 Eli Lilly and Co. Company Information
  11.2.2 Eli Lilly and Co. ADHD Medications Product Offered
  11.2.3 Eli Lilly and Co. ADHD Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Eli Lilly and Co. Main Business Overview
  11.2.5 Eli Lilly and Co. Latest Developments
11.3 Johnson and Johnson Services
  11.3.1 Johnson and Johnson Services Company Information
  11.3.2 Johnson and Johnson Services ADHD Medications Product Offered
  11.3.3 Johnson and Johnson Services ADHD Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Johnson and Johnson Services Main Business Overview
  11.3.5 Johnson and Johnson Services Latest Developments
11.4 NEOS Therapeutic
  11.4.1 NEOS Therapeutic Company Information
  11.4.2 NEOS Therapeutic ADHD Medications Product Offered
  11.4.3 NEOS Therapeutic ADHD Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 NEOS Therapeutic Main Business Overview
  11.4.5 NEOS Therapeutic Latest Developments
11.5 Takeda Pharmaceutical
  11.5.1 Takeda Pharmaceutical Company Information
  11.5.2 Takeda Pharmaceutical ADHD Medications Product Offered
  11.5.3 Takeda Pharmaceutical ADHD Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Takeda Pharmaceutical Main Business Overview
  11.5.5 Takeda Pharmaceutical Latest Developments
11.6 Pfizer
  11.6.1 Pfizer Company Information
  11.6.2 Pfizer ADHD Medications Product Offered
  11.6.3 Pfizer ADHD Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Pfizer Main Business Overview
  11.6.5 Pfizer Latest Developments
11.7 Lupin
  11.7.1 Lupin Company Information
  11.7.2 Lupin ADHD Medications Product Offered
  11.7.3 Lupin ADHD Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Lupin Main Business Overview
  11.7.5 Lupin Latest Developments
11.8 Shire
  11.8.1 Shire Company Information
  11.8.2 Shire ADHD Medications Product Offered
  11.8.3 Shire ADHD Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Shire Main Business Overview
  11.8.5 Shire Latest Developments
11.9 Mallinckrodt
  11.9.1 Mallinckrodt Company Information
  11.9.2 Mallinckrodt ADHD Medications Product Offered
  11.9.3 Mallinckrodt ADHD Medications Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Mallinckrodt Main Business Overview
  11.9.5 Mallinckrodt Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. ADHD Medications Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. ADHD Medications Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Stimulant
Table 4. Major Players of Non-stimulant
Table 5. ADHD Medications Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global ADHD Medications Market Size by Type (2020-2025) & ($ millions)
Table 7. Global ADHD Medications Market Size Market Share by Type (2020-2025)
Table 8. ADHD Medications Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global ADHD Medications Market Size by Application (2020-2025) & ($ millions)
Table 10. Global ADHD Medications Market Size Market Share by Application (2020-2025)
Table 11. Global ADHD Medications Revenue by Player (2020-2025) & ($ millions)
Table 12. Global ADHD Medications Revenue Market Share by Player (2020-2025)
Table 13. ADHD Medications Key Players Head office and Products Offered
Table 14. ADHD Medications Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global ADHD Medications Market Size by Region (2020-2025) & ($ millions)
Table 18. Global ADHD Medications Market Size Market Share by Region (2020-2025)
Table 19. Global ADHD Medications Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global ADHD Medications Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas ADHD Medications Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas ADHD Medications Market Size Market Share by Country (2020-2025)
Table 23. Americas ADHD Medications Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas ADHD Medications Market Size Market Share by Type (2020-2025)
Table 25. Americas ADHD Medications Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas ADHD Medications Market Size Market Share by Application (2020-2025)
Table 27. APAC ADHD Medications Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC ADHD Medications Market Size Market Share by Region (2020-2025)
Table 29. APAC ADHD Medications Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC ADHD Medications Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe ADHD Medications Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe ADHD Medications Market Size Market Share by Country (2020-2025)
Table 33. Europe ADHD Medications Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe ADHD Medications Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa ADHD Medications Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa ADHD Medications Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa ADHD Medications Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of ADHD Medications
Table 39. Key Market Challenges & Risks of ADHD Medications
Table 40. Key Industry Trends of ADHD Medications
Table 41. Global ADHD Medications Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global ADHD Medications Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global ADHD Medications Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global ADHD Medications Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Amneal Pharmaceuticals Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 46. Amneal Pharmaceuticals ADHD Medications Product Offered
Table 47. Amneal Pharmaceuticals ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Amneal Pharmaceuticals Main Business
Table 49. Amneal Pharmaceuticals Latest Developments
Table 50. Eli Lilly and Co. Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 51. Eli Lilly and Co. ADHD Medications Product Offered
Table 52. Eli Lilly and Co. ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Eli Lilly and Co. Main Business
Table 54. Eli Lilly and Co. Latest Developments
Table 55. Johnson and Johnson Services Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 56. Johnson and Johnson Services ADHD Medications Product Offered
Table 57. Johnson and Johnson Services ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Johnson and Johnson Services Main Business
Table 59. Johnson and Johnson Services Latest Developments
Table 60. NEOS Therapeutic Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 61. NEOS Therapeutic ADHD Medications Product Offered
Table 62. NEOS Therapeutic ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. NEOS Therapeutic Main Business
Table 64. NEOS Therapeutic Latest Developments
Table 65. Takeda Pharmaceutical Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 66. Takeda Pharmaceutical ADHD Medications Product Offered
Table 67. Takeda Pharmaceutical ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Takeda Pharmaceutical Main Business
Table 69. Takeda Pharmaceutical Latest Developments
Table 70. Pfizer Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 71. Pfizer ADHD Medications Product Offered
Table 72. Pfizer ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Pfizer Main Business
Table 74. Pfizer Latest Developments
Table 75. Lupin Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 76. Lupin ADHD Medications Product Offered
Table 77. Lupin ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Lupin Main Business
Table 79. Lupin Latest Developments
Table 80. Shire Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 81. Shire ADHD Medications Product Offered
Table 82. Shire ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Shire Main Business
Table 84. Shire Latest Developments
Table 85. Mallinckrodt Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 86. Mallinckrodt ADHD Medications Product Offered
Table 87. Mallinckrodt ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Mallinckrodt Main Business
Table 89. Mallinckrodt Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. ADHD Medications Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ADHD Medications Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. ADHD Medications Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. ADHD Medications Sales Market Share by Country/Region (2024)
Figure 8. ADHD Medications Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global ADHD Medications Market Size Market Share by Type in 2024
Figure 10. ADHD Medications in Adult
Figure 11. Global ADHD Medications Market: Adult (2020-2025) & ($ millions)
Figure 12. ADHD Medications in Children
Figure 13. Global ADHD Medications Market: Children (2020-2025) & ($ millions)
Figure 14. Global ADHD Medications Market Size Market Share by Application in 2024
Figure 15. Global ADHD Medications Revenue Market Share by Player in 2024
Figure 16. Global ADHD Medications Market Size Market Share by Region (2020-2025)
Figure 17. Americas ADHD Medications Market Size 2020-2025 ($ millions)
Figure 18. APAC ADHD Medications Market Size 2020-2025 ($ millions)
Figure 19. Europe ADHD Medications Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa ADHD Medications Market Size 2020-2025 ($ millions)
Figure 21. Americas ADHD Medications Value Market Share by Country in 2024
Figure 22. United States ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC ADHD Medications Market Size Market Share by Region in 2024
Figure 27. APAC ADHD Medications Market Size Market Share by Type (2020-2025)
Figure 28. APAC ADHD Medications Market Size Market Share by Application (2020-2025)
Figure 29. China ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 33. India ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe ADHD Medications Market Size Market Share by Country in 2024
Figure 36. Europe ADHD Medications Market Size Market Share by Type (2020-2025)
Figure 37. Europe ADHD Medications Market Size Market Share by Application (2020-2025)
Figure 38. Germany ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 39. France ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 40. UK ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa ADHD Medications Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa ADHD Medications Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa ADHD Medications Market Size Market Share by Application (2020-2025)
Figure 46. Egypt ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries ADHD Medications Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas ADHD Medications Market Size 2026-2031 ($ millions)
Figure 52. APAC ADHD Medications Market Size 2026-2031 ($ millions)
Figure 53. Europe ADHD Medications Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa ADHD Medications Market Size 2026-2031 ($ millions)
Figure 55. United States ADHD Medications Market Size 2026-2031 ($ millions)
Figure 56. Canada ADHD Medications Market Size 2026-2031 ($ millions)
Figure 57. Mexico ADHD Medications Market Size 2026-2031 ($ millions)
Figure 58. Brazil ADHD Medications Market Size 2026-2031 ($ millions)
Figure 59. China ADHD Medications Market Size 2026-2031 ($ millions)
Figure 60. Japan ADHD Medications Market Size 2026-2031 ($ millions)
Figure 61. Korea ADHD Medications Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia ADHD Medications Market Size 2026-2031 ($ millions)
Figure 63. India ADHD Medications Market Size 2026-2031 ($ millions)
Figure 64. Australia ADHD Medications Market Size 2026-2031 ($ millions)
Figure 65. Germany ADHD Medications Market Size 2026-2031 ($ millions)
Figure 66. France ADHD Medications Market Size 2026-2031 ($ millions)
Figure 67. UK ADHD Medications Market Size 2026-2031 ($ millions)
Figure 68. Italy ADHD Medications Market Size 2026-2031 ($ millions)
Figure 69. Russia ADHD Medications Market Size 2026-2031 ($ millions)
Figure 70. Egypt ADHD Medications Market Size 2026-2031 ($ millions)
Figure 71. South Africa ADHD Medications Market Size 2026-2031 ($ millions)
Figure 72. Israel ADHD Medications Market Size 2026-2031 ($ millions)
Figure 73. Turkey ADHD Medications Market Size 2026-2031 ($ millions)
Figure 74. Global ADHD Medications Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global ADHD Medications Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries ADHD Medications Market Size 2026-2031 ($ millions)